CClinicalTrials.gg
WithdrawnNCT02530775Updated Dec 16, 2015

"Is Instrumentation Necessary for "Static" Degenerative Spondylolisthesis"

An interventional study of instrumented spinal fusion with laminectomy and non-instrumented spinal fusion with laminectomy in Degenerative Spondylolisthesis and Spinal Stenosis, sponsored by University of Pittsburgh. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-12-16.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

Why this study was withdrawn
The study did not receive IRB approval and was withdrawn
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether instrumented lumbar fusion provides superior clinical outcomes in comparison to non-instrumented fusion in patients with "static" degenerative spondylolisthesis.

Read the detailed description

This study will determine whether instrumented lumbar fusion will provide superior clinical outcomes in comparison to non-instrumented fusion in patients with "STATIC" degenerative spondylolisthesis. At the time of scheduling surgery, patients who meet the inclusion/exclusion criteria will be asked to participate. Patients who agree, will be randomized to either non-instrumented or instrumented arthrodesis group. Intra-operative, peri-operative, and post-operative data will be collected and compared. The investigators predict to get very similar clinical outcomes between the two groups, with possibly less complications from the non-instrumented group and definitely a reduction in cost compared to the instrumented group.

02

Conditions studied

  • Degenerative Spondylolisthesis
  • Spinal Stenosis
03

In context

Spinal Stenosis

459 studies on the registry are indexed under Spinal Stenosis; 103 are open to participants now.

Browse Spinal Stenosis studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients with stable L4-5 spondylolisthesis on lumbar flexion and extension radiographs. Stability will be determined by the treating physician.
  2. Patients with concomitant spinal stenosis.
  3. Laminectomy at any lumbar levels of stenosis.
  4. Fusion only at L4-5 level.

Exclusion criteria

Exclusion Criteria:

  1. Prior lumbar spine surgery
  2. Multi-level spondylolisthesis
  3. Anterior interbody work/fusion
  4. Tumor
  5. Infection
  6. Trauma
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    instrumented arthrodesis

    Degenerative Spondylolisthesis and Spinal Stenosis patients having a surgical procedure. The surgical procedure is the intervention and is a spinal fusion with use of instrumentation and lumbar laminectomy. No additional "drug" or "device" intervention.

    Procedure: instrumented spinal fusion with laminectomy

  • Active comparator
    non-instrumented arthrodesis

    Degenerative Spondylolisthesis and Spinal Stenosis patients having a surgical procedure. The surgical procedure is the intervention and is a spinal fusion without the use of instrumentation and lumbar laminectomy. No additional "drug" or "device" intervention.

    Procedure: non-instrumented spinal fusion with laminectomy

Interventions

  • Procedureinstrumented spinal fusion with laminectomy

    Once determined that a patient has single level "static" degenerative spondylolisthesis and is planning to schedule surgery the patient will be approached by a research team member explaining the study and reviewing the informed consent document. If the patient chooses to participate, he or she will be randomized to be apart of the non-instrumented arthrodesis with laminectomy group or the instrumented arthrodesis with laminectomy group. Both are standard approved surgical approaches; however, using instrumentation is the more commonly used approach.

  • Procedurenon-instrumented spinal fusion with laminectomy

    Once determined that a patient has single level "static" degenerative spondylolisthesis and is planning to schedule surgery the patient will be approached by a research team member explaining the study and reviewing the informed consent document. If the patient chooses to participate, he or she will be randomized to be apart of the non-instrumented arthrodesis with laminectomy group or the instrumented arthrodesis with laminectomy group. Both are standard approved surgical approaches; however, using instrumentation is the more commonly used approach.

06

What researchers measure

Primary outcomes

  1. Functional Outcome Scores: SF-12/SF-36 Quality of Life Questionnaires

    Measured by patient outcome survey such as the SF-12 or SF-36 Questionnaire (all questions are scored on a scale from 0 to 100, with 100 representing the highest level of functioning possible)

    Time frame: Up to 2 years

  2. Functional Outcome Scores: Oswestry Disability Index (ODI) Questionnaire

    Measured by patient outcome survey such as the Oswestry Disability Index (ODI) that assesses low back pain (scoring ranges from 0 to \>35)

    Time frame: Up to 2 years

Secondary outcomes

  1. Rate of Infection

    Wound Complications

    Time frame: Expected average of 4 weeks

  2. Rate of Symptomatic Pseudoarthrosis

    Time frame: Up to 2 years

  3. Need for Revision Surgery

    Return to the OR

    Time frame: Up to 2 years

  4. Length of Hospital Stay

    Time frame: Expected average of 1 week

  5. Surgical Time

    Time frame: 2-4 hours

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02530775
Lead sponsor
University of Pittsburgh
Responsible party
Joon Yung Lee, MD (M.D., University of Pittsburgh) — Principal investigator
First posted
Aug 21, 2015
Start date
Oct 2015
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Dec 16, 2015

Study contacts

Joon Y Lee, M.D.
principal investigator · University of Pittsburgh Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion